USANA Health Sciences (USNA) Earnings Analysis

USANA Health Sciences (USNA) has no confirmed upcoming earnings date. Last quarter (2026-02-17) it beat with EPS 0.6 USD vs 0.41 USD est (+46.3%). It has beaten estimates in 2/4 recent quarters (50%). Trailing P/E 46.85.

Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades

When does USNA next report earnings?

No confirmed upcoming earnings date is currently scheduled for USNA. This page updates as the calendar is published.

USNA earnings history — beats and misses

Quarter (report date)EPS actualEPS est.SurpriseResult
2026-02-170.6 USD0.41 USD+46.3%Beat
2025-10-21-0.15 USD0.25 USD-160%Miss
2025-07-220.74 USD0.54 USD+37%Beat
2024-07-230.54 USD0.65 USD-16.9%Miss

Beat rate: 2/4 (50%) over reported quarters with consensus data.

USNA valuation and analyst view

Trailing P/E46.85
Trailing EPS0.48228 USD
Price / book0.75
Dividend yield0.00%
Market cap0.42B
Analyst consensusHold (2 buy / 5 hold / 1 sell)

Related research pages

Frequently asked questions

When is USANA Health Sciences (USNA)'s next earnings date?

No confirmed upcoming earnings date is currently scheduled for USNA. This page updates as the calendar is published.

Did USNA beat earnings last quarter?

In its 2026-02-17 report, USNA posted EPS of 0.6 USD versus a 0.41 USD estimate — a beat of 46.3%.

What is USNA's earnings track record?

Over the last 4 reported quarters with consensus data, USNA beat estimates 2 times (50%).

What is USNA's current P/E ratio and EPS?

USNA trades at a trailing P/E of 46.85 on trailing EPS of 0.4822806826829003 USD.

What do analysts rate USNA?

Analyst consensus is "Hold" across 8 ratings (0 strong buy, 2 buy, 5 hold, 1 sell, 0 strong sell).